Get started
Author

Leander Reinshagen

Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation
2022 · Kai Jakobs, Leander Reinshagen, et al. · Frontiers in Immunology · 25
PDF
The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies
2023 · Emily Parissa Ghanbari, Kai Jakobs, et al. · Biomedicines · 12
PDF
Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19
2023 · Marianna Puccini, Kai Jakobs, et al. · International Journal of Molecular Sciences · 12
PDF
Protease-Activated Receptor-1 IgG Autoantibodies in Patients with COVID-19
2023 · Leander Reinshagen, Vanasa Nageswaran, et al. · Thrombosis and Haemostasis · 4
Gut microbial metabolite imidazole propionate impairs endothelial cell function and promotes the development of atherosclerosis
2024 · Vanasa Nageswaran, Alba Carreras, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients
2023 · Erik Asmus, Weronika Karle, et al. · European Respiratory Journal · 1
PDF
Pneumonia induced rise in glucagon promotes endothelial damage and vascular thrombogenicity
2024 · Pegah Ramezani Rad, Vanasa Nageswaran, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Cystic fibrosis transmembrane conductance regulator potentiators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients
2023 · Szandor Simmons, Erik Asmus, et al. · Physiology
Parameters of coagulation and platelet hyperreactivity reflect an increased mortality in patients with moderate to severe COVID-19
2022 · K Jakobs, M Puccini, et al. · European Heart Journal
Galectin-3 as a possible marker for increased thrombogenicity in COVID-19
2022 · M Puccini, K Jakobs, et al. · European Heart Journal
PDF
Works count: 12
Citation count: 57
H-index: 4
I10-index: 3
Year
Topic
Type